Molecular diagnosis of cystic fibrosis (Q34132033)

31 July 2017

1 reference

title

Molecular diagnosis of cystic fibrosis. (English)

1 reference

31 July 2017

0 references

Antony E Shrimpton

1

1 reference

31 July 2017

publication date

1 May 2002

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

31 July 2017

published in

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

240-256

1 reference

Identification of the cystic fibrosis gene: chromosome walking and jumping

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Identification of the cystic fibrosis gene: genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Frontiers in research on cystic fibrosis: understanding its molecular and chemical basis and relationship to the pathogenesis of the disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Outwardly rectifying chloride channels and CF: A divorce and remarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Cystic fibrosis salt/fluid controversy: in the thick of it.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Prospects for gene therapy for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Human Genome Project and cystic fibrosis--a symbiotic relationship.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Genetic analysis of DNA from single human oocytes: a model for preimplantation diagnosis of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Laboratory standards and guidelines for population-based cystic fibrosis carrier screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Couple screening for cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Cystic-fibrosis-like disease unrelated to the cystic fibrosis transmembrane conductance regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Diversity of cystic fibrosis mutation-screening practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Recommendations for quality improvement in genetic testing for cystic fibrosis. European Concerted Action on Cystic Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding pitfalls in the risk calculations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Genotype and phenotype in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Genotype-phenotype correlations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Genotype-phenotype relationships in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Antagonists to the rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

A novel exon in the cystic fibrosis transmembrane conductance regulator gene activated by the nonsense mutation E92X in airway epithelial cells of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Incomplete rescue of cystic fibrosis transmembrane conductance regulator deficient mice by the human CFTR cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Molecular pathophysiology of cystic fibrosis based on the rescued knockout mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

A robotics-assisted procedure for large scale cystic fibrosis mutation analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Slowly but surely towards better scanning for mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Fluorescein-labeled oligonucleotides for real-time pcr: using the inherent quenching of deoxyguanosine nucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Clinical, genetic, and pharmacogenetic applications of the Invader assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Relation between mutations of the cystic fibrosis gene and idiopathic pancreatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Mutations of the cystic fibrosis gene in patients with chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Mutations in the cystic fibrosis transmembrane regulator gene in patients with tropical calcific pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

Use of protein repair therapy in the treatment of cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

THERAPIES DIRECTED AT THE BASIC DEFECT IN CYSTIC FIBROSIS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2.3.240

21 January 2018

Identifiers

DOI

10.1586/14737159.2.3.240

1 reference

31 July 2017

1 reference